American Gene Technologies® (AGT™) announced the launch of a new company - Addimmune™ - to continue to develop gene and cell therapy technologies to cure HIV! This video documents the official announcements!
When Jeff Galvin founded American Gene Technologies® in 2008, he envisioned a future where gene therapy could be used to write disease out of the genetic code.
On June 9, 2023, AGT launched Addimmune to focus solely on advancing an HIV cure, building upon more than a decade of work by AGT that led to a successful Phase 1 HIV gene and cell therapy clinical trial.
Addimmune aims to create tremendous benefits for HIV patients, payers, and the public. Its gene therapy technology has the power to transform millions of lives. The new company’s name represents a fusion of two fundamental concepts: using gene and cell therapy to add new capacity to the human T cell to create an improved immune system to fight HIV.
Follow Addimmune on social media:
Facebook: / addimmune
Twitter: / addimmune
LinkedIn: / addi. .
Instagram: / addimmune
Follow AGT on social media:
Facebook: / amerigene
Twitter: / americangene
LinkedIn: / amer. .
Instagram: / americangen. .
Follow Jeff Galvin on social media:
Twitter: @jeffreygalvin - / jeffreygalvin
LinkedIn: / jeff-galvin
About Addimmune
Addimmune was founded in 2023 to cure HIV with promising gene therapy technologies. Building upon the success of American Gene Technologies’ HIV clinical trial, Addimmune is solely focused on developing and commercializing an effective and lasting cure for HIV. Learn more about Addimmune in this video: • Addimmune Pursues a Cu...
About American Gene Technologies:
American Gene Technologies is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Its mission is to transform people's lives through genetic medicines that rid the body of disease. Visit our website: www.americangene.com
Subscribe to our newsletter: bit.ly/3ughPNR
Music: Inspiring Corporate Business Background by Psystein, Velimir Andreev
Негізгі бет Ғылым және технология AGT Launches New Company “Addimmune” to Focus on HIV Cure
Пікірлер: 349